Andan, Carmen R.
HRN: 28 23 30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2025
CEFTRIAXONE 1G (VIAL)
12/25/2025
12/31/2025
IV
2gm
OD
T/C CAP; T/C Complicated UTI
Checking Initial Appropriateness
12/27/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
12/27/2025
01/02/2026
PO SWISH AND SWALLOW
5ml
TID
Oral Ulcer
Checking Initial Appropriateness
12/30/2025
CEFTAZIDIME 1GM (VIAL)
12/30/2025
01/06/2026
IV
1gram
Q8h
CAP MR
Checking Final Appropriateness